AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 100 filers reported holding AKCEA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $310,000 | +80.2% | 17,114 | +36.4% | 0.00% | – |
| Q2 2020 | $172,000 | +14.7% | 12,550 | +19.6% | 0.00% | – |
| Q1 2020 | $150,000 | -7.4% | 10,495 | +10.0% | 0.00% | – |
| Q4 2019 | $162,000 | +5.9% | 9,539 | -3.9% | 0.00% | – |
| Q3 2019 | $153,000 | -77.3% | 9,927 | -65.4% | 0.00% | – |
| Q2 2019 | $673,000 | +233.2% | 28,718 | +305.5% | 0.00% | – |
| Q1 2019 | $202,000 | +102.0% | 7,082 | +111.9% | 0.00% | – |
| Q4 2018 | $100,000 | -45.9% | 3,342 | -36.8% | 0.00% | – |
| Q3 2018 | $185,000 | -36.9% | 5,289 | -57.2% | 0.00% | – |
| Q2 2018 | $293,000 | +66.5% | 12,368 | +79.8% | 0.00% | – |
| Q1 2018 | $176,000 | -15.4% | 6,878 | -42.7% | 0.00% | – |
| Q4 2017 | $208,000 | -52.7% | 11,996 | -24.6% | 0.00% | – |
| Q3 2017 | $440,000 | – | 15,914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |